SMMT
SMMT
US86627T1088
Summit Therapeutics Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
14.03B EUR
11.56B EUR
14.71B EUR
13.56B EUR
Enterprise Value
13.03B EUR
11.16B EUR
14.63B EUR
13.36B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-15.42x
--
--
--
Price to Sales
--
--
--
--
Price to Book
22.15x
18.34x
26.95x
20.58x
EV/Revenue
--
--
--
--
EV/EBITDA
-14.89x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1%
-3.98%
-2.61%
-1.93%
ende